Edwards Lifesciences (EW) Dips More Than Broader Markets: What You Should Know

Edwards Lifesciences (EW) closed the most recent trading day at $145.51, moving -1.23% from the previous trading session. This move lagged the S&P 500's daily loss of 0.04%. Meanwhile, the Dow gained 0.26%, and the Nasdaq, a tech-heavy index, lost 0.48%.

Coming into today, shares of the medical device maker had lost 2.74% in the past month. In that same time, the Medical sector lost 3.8%, while the S&P 500 lost 4.53%.

EW will be looking to display strength as it nears its next earnings release, which is expected to be October 23, 2018. The company is expected to report EPS of $1.02, up 21.43% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $925.04 million, up 12.6% from the prior-year quarter.

For the full year, our Zacks Consensus Estimates are projecting earnings of $4.67 per share and revenue of $3.82 billion, which would represent changes of +22.89% and +11.18%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for EW. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.14% higher. EW is currently a Zacks Rank #2 (Buy).

Valuation is also important, so investors should note that EW has a Forward P/E ratio of 31.51 right now. This represents a discount compared to its industry's average Forward P/E of 32.91.

We can also see that EW currently has a PEG ratio of 2.03. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Instruments stocks are, on average, holding a PEG ratio of 2.74 based on yesterday's closing prices.

The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 84, which puts it in the top 33% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Edwards Lifesciences Corporation (EW) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.